Louise McCullough

Estrogen and selective estrogen receptor modulators: neuroprotection in the Women's Health Initiative era.

Estrogen and ischemic neuroprotection: an integrated view.

Aromatase cytochrome P450 and extragonadal estrogen play a role in ischemic neuroprotection.

Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia.

Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender.

Stroke in the female: role of biological sex and estrogen.

Animal models of ischemic stroke: balancing experimental aims and animal care.

Estradiol regulates angiopoietin-1 mRNA expression through estrogen receptor-alpha in a rodent experimental stroke model.

Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection.

Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke.

Sex differences in cell death.

Social interaction improves experimental stroke outcome.

The "drip-and-ship" approach: starting IV t-PA for acute ischemic stroke at outside hospitals prior to transfer to a regional stroke center.

Acute stroke management in the elderly.

System x(c)- activity and astrocytes are necessary for interleukin-1 beta-mediated hypoxic neuronal injury.

磷酸腺苷活化蛋白激酶抑制和基因缺失的脑卒中的神经保护作用。

Akt1 gene deletion and stroke.

Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia.

Pathways to ischemic neuronal cell death: are sex differences relevant?

Effects of gender and sex steroids on ischemic injury.

Sex differences in stroke.

TTC, fluoro-Jade B and NeuN staining confirm evolving phases of infarction induced by middle cerebral artery occlusion.

Sex differences in minocycline-induced neuroprotection after experimental stroke.

Perception of risk and knowledge of risk factors in women at high risk for stroke.

Changes in experimental stroke outcome across the life span.

Sex differences in caspase activation after stroke.

Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke.

Stroke-risk perception in women: getting the message out.

Disruption of the axon initial segment cytoskeleton is a new mechanism for neuronal injury.

Effects of AMP-activated protein kinase in cerebral ischemia.

Emergency department arrival times, treatment, and functional recovery in women with acute ischemic stroke.

Sex-specific responses to stroke.

Expression of Na-K-Cl cotransporter and edema formation are age dependent after ischemic stroke.

Stroke in women: disparities and outcomes.

Thrombolysis in right versus left hemispheric stroke.

Attitudes of US medical trainees towards neurology education: "Neurophobia" - a global issue.

Mismatch: when the imaging studies conflict with the neurologic exam.

Adenosine monophosphate activated protein kinase inhibition is protective in both sexes after experimental stroke.

Sex differences in cerebral ischemia: possible molecular mechanisms.

Effects of metformin in experimental stroke.

The blood-brain barrier: geriatric relevance of a critical brain-body interface.

Estrogen enhances neurogenesis and behavioral recovery after stroke.

Sex differences in the response to poly(ADP-ribose) polymerase-1 deletion and caspase inhibition after stroke.

Middle cerebral artery occlusion model in rodents: methods and potential pitfalls.

Age-related changes in AMP-activated protein kinase after stroke.

Clinical reasoning: a case of progressive cognitive decline reversed by middle cerebral artery stent placement.

Post-stroke hypothermia provides neuroprotection through inhibition of AMP-activated protein kinase.

Sexual dimorphism in ischemic stroke: lessons from the laboratory.

miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia.

Functional recovery in aging mice after experimental stroke.

Impact of a neurointensivist on outcomes in critically ill stroke patients.

X chromosome dosage and the response to cerebral ischemia.

"Won't you be my neighbor?": deciphering the mechanisms of neuroprotection induced by social interaction.

Upregulation of fibronectin and the α5β1 and αvβ3 integrins on blood vessels within the cerebral ischemic penumbra.

Peripheral leukocyte counts and outcomes after intracerebral hemorrhage.

Impact of Emergency Department Transitions of Care on Thrombolytic Use in Acute Ischemic Stroke.

Early experience with community implementation of thrombolysis three to 4.5 hours after acute ischemic stroke.